| Ganitumab studied in …STUDIED_INderived27 of 27show fewer |
|---|
| → studied in | NCT04199026NA · recruiting Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma · 27 trials list this drug (2 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02306161Phase 3 · active not recruiting Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma · 27 trials list this drug (2 active) | — | — | Ewing Sarcoma,Peripheral Primitive Neuroectodermal Tumor of Bone,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01318642Phase 2 · terminated Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas · 27 trials list this drug (2 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00630552Phase 1/Phase 2 · completed QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer · 27 trials list this drug (2 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00807612Phase 1/Phase 2 · terminated QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer · 27 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00626106Phase 2 · completed QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer · 27 trials list this drug (2 active) | — | — | Breast Neoplasm,Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00791154Phase 1/Phase 2 · terminated QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer · 27 trials list this drug (2 active) | — | — | Solid Neoplasm,Malignant Lung Neoplasm,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00819169Phase 1/Phase 2 · terminated QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors · 27 trials list this drug (2 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00788957Phase 1/Phase 2 · completed Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) · 27 trials list this drug (2 active) | — | — | Malignant Digestive System Neoplasm,Malignant Colorectal Neoplasm,Malignant Colon Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04129151Phase 2 · terminated Palbociclib + Ganitumab In Ewing Sarcoma · 27 trials list this drug (2 active) | — | — | Sarcoma,Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00891930Phase 2 · completed Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab · 27 trials list this drug (2 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231347Phase 3 · completed QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas · 27 trials list this drug (2 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Malignant Endocrine Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03041701Phase 1/Phase 2 · terminated Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma · 27 trials list this drug (2 active) | — | — | Rhabdomyosarcoma,Alveolar Rhabdomyosarcoma,Embryonal Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01327612Phase 2 · completed Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) · 27 trials list this drug (2 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01562899Phase 1/Phase 2 · terminated A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors · 27 trials list this drug (2 active) | — | — | Melanoma with BRAF Mutation,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03029481no longer available Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma · 27 trials list this drug (2 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01708161Phase 1/Phase 2 · terminated A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors · 27 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01024387Phase 2 · completed AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors · 27 trials list this drug (2 active) | — | — | Neuroendocrine Tumor,Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00563680Phase 2 · completed QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors · 27 trials list this drug (2 active) | — | — | Primitive Neuroectodermal Tumor,Sarcoma,Ewing Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00813605Phase 2 · completed QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma · 27 trials list this drug (2 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00974896Phase 1 · completed QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors · 27 trials list this drug (2 active) | — | — | Neoplasm,Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01479179Phase 1/Phase 2 · withdrawn Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab · 27 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01473303Phase 1/Phase 2 · withdrawn Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer · 27 trials list this drug (2 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00718523Phase 2 · terminated Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer · 27 trials list this drug (2 active) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719212Phase 2 · completed Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer · 27 trials list this drug (2 active) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01298401Phase 1 · completed Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas · 27 trials list this drug (2 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00562380Phase 1 · completed AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma · 27 trials list this drug (2 active) | — | — | Adult Solid Neoplasm,Lymphoma,Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |